Evidence map›Paper›PMID 26838737›Full record

ArticleJournal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban2016

Expression and clinical significance of IL-17 and IL-17 receptor in ulcerative colitis.

Heng Zhang, Bing Xia, Jin Li, Qiu Zhao, Zhi-Tao Chen, Rui Zhou, Jie Wu

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Network pharmacology and molecular docking reveal the immunomodulatory mechanism of rhubarb peony decoction for the treatment of ulcerative colitis and irritable bowel syndrome.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Heng ZhangDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University; Clinical Research Center for Intestinal & Colorectal Diseases of Hubei Province, and Key Laboratory of Allergy and Immune-related Diseases, Wuhan, 430071, China.
Bing XiaDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University; Clinical Research Center for Intestinal & Colorectal Diseases of Hubei Province, and Key Laboratory of Allergy and Immune-related Diseases, Wuhan, 430071, China.
Jin LiDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University; Clinical Research Center for Intestinal & Colorectal Diseases of Hubei Province, and Key Laboratory of Allergy and Immune-related Diseases, Wuhan, 430071, China. 15071178164@163.com.
Qiu ZhaoDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University; Clinical Research Center for Intestinal & Colorectal Diseases of Hubei Province, and Key Laboratory of Allergy and Immune-related Diseases, Wuhan, 430071, China.
Zhi-Tao ChenDepartment of Gastroenterology, the Central Hospital of Wuhan, Wuhan, 430014, China.
Rui ZhouDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University; Clinical Research Center for Intestinal & Colorectal Diseases of Hubei Province, and Key Laboratory of Allergy and Immune-related Diseases, Wuhan, 430071, China.
Jie WuDepartment of Gastroenterology, Zhongnan Hospital of Wuhan University; Clinical Research Center for Intestinal & Colorectal Diseases of Hubei Province, and Key Laboratory of Allergy and Immune-related Diseases, Wuhan, 430071, China.
Zhongnan Hospital of Wuhan University · CNCentral Hospital of Wuhan · CNWuhan Prevention and Treatment Center for Occupational Diseases · CNWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to determine the expression levels of IL-17 in serum and IL-17 receptor (IL-17R) in intestinal mucosa tissue in patients with ulcerative colitis (UC) and controls, and evaluate their relationship with disease activity and explore the role of IL-17 in the patho-genesis of UC. A total of 36 Chinese UC patients and 60 healthy controls were enrolled in this study. Serum IL-17 and C-reactive protein (CRP) levels were determined by ELISA and immunonephelometry, respectively. The IL-17R mRNA expression levels were detected by quantitative PCR. Serum IL-17 levels were significantly elevated in UC patients as compared with those in the healthy controls (P<0.05). Among UC patients, serum IL-17 levels were significantly increased in active phase as compared with those in inactive phase (P<0.05), and correlated with CRP levels (r=0.578, P<0.01). IL-17R expression levels were higher in active UC patients than in healthy controls (P<0.05). It was concluded that IL-17 levels were highly expressed in UC, especially in active phase, and correlated with CRP levels in UC patients.

Indexed as

AdultBiomarkersCase-Control StudiesColitis, UlcerativeC-Reactive ProteinFemaleHumansInterleukin-17MaleMiddle AgedReceptors, Interleukin-17RNA, MessengerBiomarkersC-Reactive ProteinInterleukin-17Receptors, Interleukin-17RNA, Messengerinterleukin-17interleukin-17 receptorintestinal mucosaserumulcerative colitis

Identifiers

PMID26838737
OpenAlexW2338123534

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.